High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm

被引:65
作者
Venturi, M [1 ]
Seifert, C [1 ]
Hunte, C [1 ]
机构
[1] Max Planck Inst Biophys, Abt Mol Membranbiol, D-60528 Frankfurt, Germany
关键词
antibody; Fab fragments; overproduction; oxidizing bacterial cytoplasm; functionality;
D O I
10.1006/jmbi.2001.5221
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The antigen-binding fragments (Fab) of antibodies are powerful tools in clinical therapy, molecular diagnostics and basic research. However, their principal applications require pure recombinant molecules in large amounts, which are challenging to obtain. Severe limitations in yield, folding and functionality are commonly encountered in bacterial production of Fab fragments. Secretion into the oxidizing periplasm generally results in low yield, whereas expression in the reducing cytoplasmic environment produces unfolded or non-functional protein. We hypothesized that an impaired reducing environment of the cytoplasm would permit correctly folded, functional cytoplasmic expression of Fabs with high yield. We used the Escherichia coli strain FA113, which has no activity of both thioredoxin and glutathione reductase, and thus has an oxidizing cytoplasmic environment. With the newly constructed vector pFAB1 we tested the cytoplasmic expression of two Fab fragments, which recognize the integral membrane protein NhaA, a bacterial Na+/H+ antiporter. These antibodies differ in terms of DNA sequence and stability. Both antibody fragments were produced to very high yields (10-30 mg/l from bacterial cultures at an A(600 nm) = 1.2-1.3). This is a factor 50-250 times higher than any other reported over-expression strategy for Fab fragments and currently represents the highest production rate ever been reported for antibody Fab fragments in bacteria grown to similar cell densities. The fragments are fully functional and can be efficiently purified by His-tag chromatography. Expression of active Fab fragments in the bacterial cytoplasm unlocks the possibility of using antibody specific targeting in an intracellular environment. Such a capacity opens new perspectives for investigating metabolic and regulatory pathways in vivo and also provides a powerful selection system for functional genomics. (C) 2002 Academic Press.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 28 条
[1]   Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm [J].
Bessette, PH ;
Åslund, F ;
Beckwith, J ;
Georgiou, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :13703-13708
[2]   CRYSTALLIZATION AND PRELIMINARY-X-RAY DIFFRACTION STUDY OF THE BACTERIALLY EXPRESSED FV FROM THE MONOCLONAL ANTILYSOZYME ANTIBODY D1.3 AND OF ITS COMPLEX WITH THE ANTIGEN, LYSOZYME [J].
BOULOT, G ;
EISELE, JL ;
BENTLEY, GA ;
BHAT, TN ;
WARD, ES ;
WINTER, G ;
POLJAK, RJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 213 (04) :617-619
[3]   Glycine betaine-assisted protein folding in a lysA mutant of Escherichia coli [J].
Bourot, S ;
Sire, O ;
Trautwetter, A ;
Touzé, T ;
Wu, LF ;
Blanco, C ;
Bernard, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) :1050-1056
[4]  
BREITLING F, 1999, RECOMBINANT ANTIBODI
[5]   HIGH-LEVEL ESCHERICHIA-COLI EXPRESSION AND PRODUCTION OF A BIVALENT HUMANIZED ANTIBODY FRAGMENT [J].
CARTER, P ;
KELLEY, RF ;
RODRIGUES, ML ;
SNEDECOR, B ;
COVARRUBIAS, M ;
VELLIGAN, MD ;
WONG, WLT ;
ROWLAND, AM ;
KOTTS, CE ;
CARVER, ME ;
YANG, M ;
BOURELL, JH ;
SHEPARD, HM ;
HENNER, D .
BIO-TECHNOLOGY, 1992, 10 (02) :163-167
[6]   Therapeutic antibody expression technology [J].
Chadd, HE ;
Chamow, SM .
CURRENT OPINION IN BIOTECHNOLOGY, 2001, 12 (02) :188-194
[7]   Therapeutic antibody fragments with prolonged in vivo half-lives [J].
Chapman, AP ;
Antoniw, P ;
Spitali, M ;
West, S ;
Stephens, S ;
King, DJ .
NATURE BIOTECHNOLOGY, 1999, 17 (08) :780-783
[8]   SINGLE-STEP PURIFICATION OF A BACTERIALLY EXPRESSED ANTIBODY F-V FRAGMENT BY IMMOBILIZED METAL AFFINITY-CHROMATOGRAPHY IN THE PRESENCE OF BETAINE [J].
ESSEN, LO ;
SKERRA, A .
JOURNAL OF CHROMATOGRAPHY A, 1993, 657 (01) :55-61
[9]  
FIEDLER M, 2001, ANTIBODY ENG
[10]   F(ab′)2 molecules made from Escherichia coli produced Fab′ with hinge sequences conferring increased serum survival in an animal model [J].
Humphreys, DP ;
Vetterlein, OM ;
Chapman, AP ;
King, DJ ;
Antoniw, P ;
Suitters, AJ ;
Reeks, DG ;
Parton, TAH ;
King, LM ;
Smith, BJ ;
Lang, V ;
Stephens, PE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1998, 217 (1-2) :1-10